Tenderwize
Back to tender search

Open house Arzneimittelrabattverträge Airpiprazol Depot-Injektionssuspension

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Jul 03, 2027 · 321 days left·Open·Supplies·Framework
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Airpiprazol in der Darreichungsform Depot-Injektionssuspension, ATC N05AX12

60/100

Opportunity Score

PromisingLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

60 / 100

Complexity

20 / 100

Risk factors

No estimated value or guaranteed minimum volumes; financial return is uncertain.

The open-house model is not subject to procurement law, but the notice includes a voluntary standstill period of 10 day...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Strong opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Aug 2027
  • Non-exclusive rebate agreements for Aripiprazole depot injection suspension (ATC N05AX12) under §130a Abs. 8 SGB V.
  • All interested pharmaceutical companies can conclude identical, non-negotiable rebate agreements.
Show full summary

This is an open-house model (not a competitive procurement) by AOK Bayern to conclude non-exclusive rebate agreements with all interested pharmaceutical companies for the active ingredient Aripiprazole in depot injection suspension (ATC N05AX12). Any eligible pharmaceutical company can join at any time during the contract period (01.09.2025 to 31.08.2027), with the final deadline for signing 03.07.2027. No estimated value is provided. The procedure is not subject to procurement law. Only the structured data and TED XML notice were analyzed; no procurement documents were examined.

Risks

No estimated value or guaranteed minimum volumes; financial return is uncertain.

The open-house model is not subject to procurement law, but the notice includes a voluntary standstill period of 10 day...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical company (pharmazeutischer Unternehmer).

Administrative

  • Submit signed and completed self-declaration of reliability.
  • Submit signed contract and annex listing the medicinal products.

Requirements may be incomplete.

Award Criteria

Lot 1

No award criteria – open-house model.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open house Arzneimittelrabattverträge Airpiprazol Depot-Injektionssuspension

Non-exclusive rebate agreement for Aripiprazole depot injection suspension (ATC N05AX12) with AOK Bayern. Any pharmaceutical company meeting eligibility can join. Contract period 01.09.2025-31.08.2027, with possible termination. No estimated value.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Aug 2025 - Aug 2027

Category

Pharmaceutical products

Award Criteria

No award criteria – open-house model.

Procurement Details

Publication date
13 Jul 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
456665-2025

Documents (2)

Similar tenders